Endra Life Sciences Inc (NDRA)

[apollo1452]

Just for you "biotech_researcher" from the 5/14/19 CC during Q&A session, Michael Thornton, NDRA Chief Technology Officer clearly stated:

"The initial study as approved being a first time use device is to only do it on healthy volunteers. Most of the REB and health agencies like you try in new technologies on healthy subjects before going to compromise and complicated cases. So now that we've had this - we'll have this base of 50 or so healthy volunteers, the various boards that approve the protocols, feel much more comfortable than extending to clinics and patients that are actually in some form of liver care."